Aadi Bioscience, Inc. (AADI)

NASDAQ: AADI · IEX Real-Time Price · USD
24.51
1.25 (5.37%)
At close: Jan 14, 2022 4:00 PM
23.86
-0.65 (-2.65%)
After-hours:Jan 14, 2022 7:50 PM EST
Market Cap512.11M
Revenue (ttm)n/a
Net Income (ttm)-100.81M
Shares Out20.89M
EPS (ttm)-8.90
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend DateAug 27, 2021
Volume142,106
Open23.20
Previous Close23.26
Day's Range23.00 - 24.80
52-Week Range0.95 - 32.99
Betan/a
Analystsn/a
Price Targetn/a
Earnings DateNov 9, 2021

About AADI

Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing precision therapies for genetically-defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, ABI-009 (FYARRO) is a form of sirolimus bound to albumin. Aadi is evaluating ABI-009 in cancers with known mTOR pathway activation, including tumor agnostic indications targeting specific genomic alterations that activate the mTOR pathway. The company was founded in 2011 and is headquartered in Pacific Palisades, California.

IndustryBiotechnology
Founded2011
Employees21
Stock ExchangeNASDAQ
Ticker SymbolAADI
Full Company Profile

Financial Performance

Financial Statements

News

Aadi Bioscience to Present at 2022 H.C. Wainwright BioConnect Virtual Conference

LOS ANGELES, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (“Aadi”), a biopharmaceutical company focusing on precision therapies for genetically-defined cancers with alterations in mTOR pathwa...

1 week ago - GlobeNewsWire

Aadi Bioscience Shares Rally On FDA Approval For Its First Product For Rare Form Cancer

The FDA has approved Aadi Bioscience Inc's (NASDAQ: AADI) Fyarro (sirolimus protein-bound particles for injectable suspension) (albumin-bound) for perivascular epithelioid cell tumor (PEComa). The appro...

1 month ago - Benzinga

Aadi Bioscience Announces FDA Approval of its First Product FYARRO™ for Patients with Locally Advanced Unresectable o...

LOS ANGELES, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (“Aadi”) (Nasdaq: AADI), a biopharmaceutical company focusing on precision therapies for genetically-defined cancers with alterations...

1 month ago - GlobeNewsWire

UPDATE – Aadi Bioscience Presents Two Abstracts on FYARRO (nab-Sirolimus) at the Annual Meeting of the Connective Tis...

LOS ANGELES, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (“Aadi”) (Nasdaq: AADI), a clinical-stage biopharmaceutical company focusing on precision therapies for genetically-defined cancers w...

2 months ago - GlobeNewsWire

Aadi Bioscience Presents Two Abstracts on FYARRO (nab-Sirolimus) at the Annual Meeting of the Connective Tissue Oncol...

LOS ANGELES, Nov. 13, 2021 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (“Aadi”) (Nasdaq: AADI), a clinical-stage biopharmaceutical company focusing on precision therapies for genetically-defined cancers w...

2 months ago - GlobeNewsWire

Aadi Bioscience, Inc. (AADI) Reports Q3 Loss, Misses Revenue Estimates

Aadi Bioscience, Inc. (AADI) delivered earnings and revenue surprises of -132.20% and -100.00%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the s...

2 months ago - Zacks Investment Research

Aadi Reports Third Quarter 2021 Financial Results and Provides Business Update

LOS ANGELES, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (“Aadi”) (Nasdaq: AADI), a clinical-stage biopharmaceutical company focusing on precision therapies for genetically-defined cancers w...

2 months ago - GlobeNewsWire

Aadi Bioscience Appoints Scott Giacobello as Chief Financial Officer

LOS ANGELES, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (“Aadi”) (Nasdaq: AADI), a clinical-stage biopharmaceutical company focusing on precision therapies for genetically-defined cancers w...

2 months ago - GlobeNewsWire

Aadi Bioscience Appoints Loretta Itri as Chief Medical Officer

LOS ANGELES, Oct. 25, 2021 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (“Aadi”) (Nasdaq: AADI), a clinical-stage biopharmaceutical company focusing on precision therapies for genetically-defined cancers w...

2 months ago - GlobeNewsWire

Aadi Bioscience Announces Publication of its Phase 2 Registrational (AMPECT) Trial of nab-Sirolimus in Patients with ...

Results Published from First Clinical Trial in this Rare Disease Results Published from First Clinical Trial in this Rare Disease

2 months ago - GlobeNewsWire

Aadi Bioscience to Participate in H.C. Wainwright's 2nd Annual Precision Oncology Conference 2021

LOS ANGELES, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (“Aadi”), a privately-held clinical-stage biopharmaceutical company focusing on precision therapies for genetically-defined cancers w...

2 months ago - GlobeNewsWire

Aadi Bioscience to Present New Preclinical Data on nab-Sirolimus (ABI-009) at AACR-NCI-EORTC Virtual International Co...

- Poster Presentation to go Live on October 7, 2021 at 9 a.m. ET and on Demand at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics -

3 months ago - GlobeNewsWire

Aadi Bioscience Appoints Brendan Delaney as Chief Operating Officer

LOS ANGELES, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (“Aadi”) (Nasdaq: AADI), a clinical-stage biopharmaceutical company focusing on precision therapies for genetically-defined cancers ...

3 months ago - GlobeNewsWire

Aadi Bioscience Appoints Emma Reeve to its Board of Directors

LOS ANGELES, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (“Aadi”) (Nasdaq: AADI), a clinical-stage biopharmaceutical company focusing on precision therapies for genetically-defined cancers ...

4 months ago - GlobeNewsWire

Top Penny Stocks to Buy? Here's 3 That Investors Are Watching

Why investors are watching these penny stocks right now The post Top Penny Stocks to Buy? Here's 3 That Investors Are Watching appeared first on Penny Stocks to Buy, Picks, News and Information | PennyS...

Other symbols:ABEVPHUN
4 months ago - PennyStocks

Best Penny Stocks To Buy Right Now? 5 To Watch Before September

Looking for penny stocks to buy now? The post Best Penny Stocks To Buy Right Now?

Other symbols:INUVMICTMNKDRLX
5 months ago - PennyStocks

Aerpio Reports Second Quarter 2021 Financial Results and Provides Business Update

CINCINNATI, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. (“Aerpio”) (Nasdaq: ARPO), a biopharmaceutical company, today reported financial results for the three and six months ended Jun...

5 months ago - GlobeNewsWire

Penny Stocks to Buy Right Now? 4 For Your Late July Watchlist

Looking For the Best Penny Stocks to Watch in July? Check These 4 Out The post Penny Stocks to Buy Right Now?

Other symbols:CFMS
5 months ago - PennyStocks

Hot Penny Stocks to Buy Now? 6 Reopening Stocks To Watch In July 2021

Reopening penny stocks are showing momentum right now; here's 6 to watch The post Hot Penny Stocks to Buy Now? 6 Reopening Stocks To Watch In July 2021 appeared first on Penny Stocks to Buy, Picks, News...

Other symbols:ABEVADXSAHTGSATSONM
5 months ago - PennyStocks

Best Biotech Penny Stocks to Buy in July 2021? 6 For Your Watchlist

Biotech penny stocks are in focus; here's 4 to watch right now The post Best Biotech Penny Stocks to Buy in July 2021? 6 For Your Watchlist appeared first on Penny Stocks to Buy, Picks, News and Informa...

Other symbols:ACSTCHEKSEELWORX
6 months ago - PennyStocks

INVESTIGATION ALERT: Halper Sadeh LLP Investigates ONEM, SYKE, NETE, CHMA, SOLY, ARPO; Shareholders are Encouraged to...

NEW YORK , July 10, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: 1Life Healthcare, Inc. (NASDAQ: ONEM)  concerning pot...

Other symbols:ONEMSOLY
6 months ago - PRNewsWire

Why Aerpio Shares Are Skyrocketing Today

Shares of microcap biopharma Aerpio Pharmaceuticals, Inc. (ARPO) are advancing strongly Thursday on above-average volume. The upside in reaction a positive analyst action.

6 months ago - Benzinga

ARPO Stock: 12 Things to Know About Aerpio Pharma as Analyst Upgrade Sends Shares Soaring

Aerpio Pharmaceuticals (ARPO) stock is flying high on Thursday after an analyst upgrade gave the company's shares a boost today. The post ARPO Stock: 12 Things to Know About Aerpio Pharma as Analyst Upg...

6 months ago - InvestorPlace

Which Penny Stocks Are Investors Buying Right Now? 7 For Your Watchlist

Why investors are watching these 7 penny stocks right now The post Which Penny Stocks Are Investors Buying Right Now? 7 For Your Watchlist appeared first on Penny Stocks to Buy, Picks, News and Informat...

Other symbols:ABUSCRBPDBGIJFUNBYNXE
6 months ago - PennyStocks

Aerpio Provides Second Update on Aadi Bioscience Presentation at the ASCO 2021 Virtual Meeting

CINCINNATI, June 04, 2021 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. (“Aerpio”) (Nasdaq: ARPO) announced that Aadi Bioscience, Inc. (“Aadi”), a privately-held biopharmaceutical company focusing on...

7 months ago - GlobeNewsWire